Statistical considerations when using a composite endpoint for comparing treatment groups

DOI10.1002/SIM.5547WikidataQ61732900 ScholiaQ61732900MaRDI QIDQ94829

Stephen W. Lagakos

Publication date: 1 August 2012

Published in: Statistics in Medicine (Search for Journal in Brave)

Related Items (1)

CompAREdesign

This page was built for publication: Statistical considerations when using a composite endpoint for comparing treatment groups